Sabra Health Care REIT (SBRA) to Release Quarterly Earnings on Monday

Sabra Health Care REIT (NASDAQ:SBRA) is anticipated to announce its Q1 2025 earnings results after the market closes on Monday, May 5th. Analysts expect the company to announce earnings of $0.36 per share and revenue of $180.23 million for the quarter. Sabra Health Care REIT has set its FY 2025 guidance at 1.430-1.460 EPS.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.36. The firm had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. On average, analysts expect Sabra Health Care REIT to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Sabra Health Care REIT Trading Down 0.5 %

NASDAQ SBRA opened at $17.42 on Monday. The stock has a market capitalization of $4.14 billion, a price-to-earnings ratio of 32.87, a PEG ratio of 1.97 and a beta of 0.93. The business’s fifty day moving average is $17.14 and its 200-day moving average is $17.52. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. Sabra Health Care REIT has a one year low of $13.82 and a one year high of $20.03.

Sabra Health Care REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.89%. The ex-dividend date of this dividend was Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio is 226.42%.

Analyst Ratings Changes

SBRA has been the subject of several research analyst reports. JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a research note on Tuesday, January 7th. Truist Financial lifted their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Tuesday, March 18th. Finally, Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $19.33.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.